NCT06918665 - HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

August 1, 2026

Conditions

Scabies

Interventions

DRUG

ivermectin infant formula preparation

The ivermectin infant formula preparation is produced by micronizing the standard 3mg ivermectin tablet and then blending it with Stage 1 infant formula (Blackmores brand) to produce a homogenous powder. This powder blend of ivermectin and infant formula is then filled into food grade clear capsules.

DRUG

Standard ivermectin 3mg tablet

standard 3mg ivermectin tablet

Trial Locations (1)

3016

The Royal Children's Hospital, Melbourne